RPA1 and cancer: In the cancer cells treated by the combination of ATL and olaparib, the markedly increased levels of γH2AX and chromatin-bound RPA indicated intense replication stress [50, 53], and the CIdU and IdU labeling experiment revealed severe fork stalling.